Forefront Medical Technology

Home » Posts tagged 'medical contract manufacturing'

Tag Archives: medical contract manufacturing

Q32019 Newsletter

Q3 2019 Forefront newsletter_Page_1

The latest issue of Forefront Medical Technology’s newsletter is available for download. In this issue, we look at outsourcing and intellectual property protection, discussing key issues such as product design ownership, contract manufacturing business models that may provide better IP protection and the benefits of a legal framework that supports IP protection. Read the full issue here.

IP Protection: Four Areas Sourcing Teams Should Audit

WP_34 IP Protection_Four Areas to Audit at Your Contract Manufacturer_Page_1Intellectual property (IP) is the core of competitive advantage. When products are outsourced, the contract manufacturer performing the final assembly typically has access to the complete documentation package for the products they build. Where are the checks and balances? How can be certain your company’s IP will be protected? In this whitepaper, Forefront Medical Technology, a specialty contract manufacturer with a focus in disposable diagnostic, drug delivery systems and medical device systems, looks at four areas sourcing teams should audit in determining the ability of their contract manufacturer to support their IP protection needs.

These are:

  • Company business model
  • Supply chain management/documentation control practices
  • Level of vertical integration
  • Legal protections within the contract manufacturers headquarters’ country.

Read the full whitepaper here.

Q12019 Newsletter

Q1 2019 Forefront newsletterForefront Medical Technology’s Q1 2019 newsletter provides a quick overview of RoHS 3 and its impact on plasticizers known as phthalates and a look at the “business case” behind good outsourcing strategy. Forefront’s 20% stake in Arrow Medical Limited in the U.K, is also discussed. Read the full issue here.

RoHS III and Phthalates: Can Your Contract Manufacturer Support Changing Requirements?

WP_32 RoHS III and Phthalates_Can Your Contract Manufacturer Support Changing Requirements_Page_1Regulatory changes can have significant impact on product design and market competitiveness. One upcoming example of this impact is the expansion of the European Union’s (EU) list of Restricted or Hazardous Substances, commonly referred to as RoHS 3. The phthalates added to the list are driving a switch from polyvinyl chloride (PVC) to polyurethane (PU) in medical products including tubing, catheters and bags. As with other RoHS directives, regions outside the EU have followed suit in legislation that restricts these substances. And, economies of scale considerations ultimately drive medical device manufacturers to alternatives which are not restricted in any market. Forefront Medical Technology’s latest whitepaper looks at the implications of this legislation and ways a contract manufacturing partner can assist in the effort to fully evaluate the range of acceptable alternatives, the cost impact of a change, and efficient development and commercialization of products utilizing the chosen alternative materials. Read the full paper here.

Visit Forefront At MD&M West Booth #1792

forefrontmedicaltechnology_mdm_600x250

Forefront Medical Technology will be exhibiting at MD&M West at the Anaheim Convention Center on Feb. 5-7. Click here and use code SPECIALFOR406 to register for a free pass to the exhibits and a 20% discount on the conference price.

 

Do Your Contract Manufacturer’s Capabilities Support Your Manufacturing Regionalization Strategy?

WP27_Do Your Contract Manufacturer_s Capabilities Support Your Manufacturing Regionalization Strategy 061518_Page_1Regionalized outsourcing strategies continue to grow in popularity. Gone are the days of shifting outsourcing to the lowest cost emerging market location. Today, most companies base sourcing strategies on a complex equation of factors driving total cost. When all these factors are considered, locating manufacturing within regions close to each end market often results in the greatest degree of responsiveness to market demand and lowest total cost. The underlying logic behind any regionalization strategy is that proximity to the end market reduces logistics costs and complexity; reduces raw material and finished goods shipping time; decreases finished goods safety stock requirements; and contributes to superior quality by minimizing unnecessary handling, transport and inspections. The question becomes: can the contract manufacturer your company selects enable your company to leverage the benefits of a regionalization strategy in your chosen end markets?

In this whitepaper, Forefront Medical Technology, a specialty contract manufacturer with a focus in disposable diagnostic, drug delivery systems and medical device systems highlights several areas to evaluate in determining whether or not a supplier’s capabilities are likely to deliver lowest total cost of ownership (TCO). Read the full paper here.

Q2 2018 Newsletter

Q2 2018 Forefront newsletterForefront Medical Technology’s Q2 2018 newsletter is out. The issue includes a list of questions to ask to determine if a contract manufacturer is a good fit for your project’s requirements, the design benefits of selecting a contract manufacturer with a broad range of production capabilities and a case study related to a specialty drug delivery system. Read the full issue here.